Scientists 1 step closer to developing treatment for chikungunya
February 16th, 2011 - 3:45 pm ICT by ANINew Delhi, Feb 16 (ANI): Scientists have moved a step closer to developing a treatment for chikungunya, a disease spread by the Aedes mosquito.
According to Straits Times, scientists from Singapore and France have discovered two antibodies that could fight against chikungunya, a disease that currently has no available vaccine or specific treatment.
The two monoclonal antibodies, which were developed from single cells, could neutralize several strains of the virus in a laboratory setting, reports English.news.cn.
The team, from the Singapore Immunology Network and French biopharmaceutical company Vivalis and led by Lucile Warter, started research in August 2009 using B cells - the white blood cells that play a key role in immunity.
The cells were taken from a donor infected with chikungunya and given the ability to proliferate indefinitely, amplified and cloned.
The scientists then used the cells to identify and generate the antibodies using a specific technique of Vivalis.
The technology was the only one that enabled the scientists to identify and generate human monoclonal antibodies, which are more efficient and have less side effects than conventional polyclonal drugs developed from multiple cells, said Warter.
The antibodies work by binding more efficiently with antigens, foreign particles that enter the body, as they target only certain kinds of antigens.
Warter said the treatment would not be a vaccine but a passive immunotherapy, adding that the treatment could be in the market in perhaps 10 years.
The finding has been published last month in the Journal of Immunology. (ANI)
- Discovery enables quicker diagnosis of chikunguyna - Mar 15, 2012
- India-Cuba joint discovery in biomedical sciences wins award - Jul 19, 2011
- Major advance in fight against autoimmune diseases and allergies - Apr 24, 2011
- Experimental vaccine shows promise against chikungunya - Mar 05, 2010
- Vaccine offers hope to treat chikungunya - Aug 14, 2011
- Promising target for AIDS vaccine identified - Apr 01, 2011
- Researchers cure type 1 diabetes in mice - Apr 09, 2010
- New findings bring scientists closer to an effective HIV vaccine - Jan 15, 2011
- Virus-like particle vaccine could offer protection against chikungunya virus - Jan 29, 2010
- Edible vaccine for malaria on way - Dec 31, 2010
- Cuba launches world's first lung cancer retardant - Sep 07, 2011
- Groundbreaking technology to detect Alzheimer's developed - Jan 07, 2011
- Breast milk antibodies help neutralize HIV - May 23, 2012
- Russia tests HIV vaccine - Feb 06, 2012
- Will a female birth control vaccine work? - Mar 13, 2011
Tags: 10 years, aedes mosquito, b cells, biopharmaceutical company, chikungunya, english news, human monoclonal antibodies, immunity, immunology, key role, mosquito, New Delhi, particles, passive immunotherapy, scientists, strains, straits times, vivalis, warter, white blood cells